You are here: Home / Public

Public

ENATRANS - Enabling Nanomedicine Translation

ENATRANS’ main objective is to network and support SMEs in translation of nanomedicine in Europe by providing a one-stop-shop service to interact and share information, experience and advice with up-to-date information and interactive tools, but also enabling personal contacts.

Nanomedical_Translation_Map_header

ENATRANS - Enabling Nanomedicine Translation

ENATRANS’ main objective is to network and support SMEs in translation of nanomedicine in Europe by providing a one-stop-shop service to interact and share information, experience and advice with up-to-date information and interactive tools, but also enabling personal contacts.

 

To be successful SMEs need to understand the requirements of the complex ecosystem made up of regulatory and reimbursement agencies, as well as the requirements of large industrial companies and clinical needs. ENATRANS will gather and provide information about approval processes, regulatory authorities and agencies, clinical and market data, and specific nanomedicine value chain analysis, relevant SME support projects and organisations. ENATRANS will convert this critical information in dedicated learning programs and tools dedicated to translation of nanomedicine.


ENATRANS aims at implementing the concept of a Translation Advisory Board (TAB) as central element of the ETPN White Paper. A TAB will be set-up with senior experienced translation experts to guide R&D teams (in SMEs and research institutes) along the translation process to successfully make it to clinical trials and later to the market. Promising projects identified and supported by the TAB need access to clinical centers for first studies in patients, which are able to handle the specificity of new nanotechnology based therapeutics. In addition, financial resources are needed to go pass the regulatory and scale-up processes, which often require funding from investors and/or large companies. ENATRANS will build bridges to clinical trial centers, investors and large companies.


Promising projects need guidance to successfully master privileged contacts with the medical, the business or the investment community. ENATRANS will deliver special coaching sessions prior to showcasing of promising projects.


Partners in ENATRANS are VDI/VDE-IT hosting the ETPN Secretariat, Nanobiotix, CEA-Leti, bioanalytik-muenster, Tel Aviv University, Fondazione Don Gnocchi and TecMinho.

 

ENATRANS Logo 

ENATRANS Services

ENATRANS Services
ENATRANS created a set of services dedicated to the larger European nanobiomedical ecosystem and aiming at providing individual actors with information, knowledge, advices, promotion, contacts in order to improve the translation of nanobiomedical technologies.
Ecosystem of Nanomedicine
Translation Advisory Board
SME Square
Nanomed Award

News

LogonanomedtalkJune2015.jpg
ENATRANS News
Press Releases
EU-NCL- First call for characterisation of injectable nanomedicines addressing cancer
The recently established European Nanomedicine Characterisation Laboratory (EU-NCL) aims at providing critical infrastructure and characterisation services that are needed to analyse physical and chemical attributes, in vitro biological properties, and in vivo characteristics of emerging nanomedicines ready for translation and clinical trials.
Interview of Dr. Klaus-Michael Weltring - Nanotechnology: a key to the future of medicine Interview
The COMPAMED Magazine interviewed the ENATRANS Partner Klaus-Michael Weltring to discuss about expectations, achievements, gaps and barriers for future medical products based on naotechnologies.
EMA PRIME: an opportunity for the translation of Nanomedicine?
The European Medicines Agency (EMA) launched PRIME (PRIority MEdicines), a new scheme to enhance support for the development of medicines that target an unmet medical need. This voluntary scheme is based on enhanced interaction and early dialogue with developers of promising medicines, to optimise development plans and speed up evaluation so these medicines can reach patients earlier.
First European Nanomed "Who's who"
The first "Who's who" dedicated to European SMEs in nanomedicine is about to go live!
Nanomedicine Award 2017: applications are now open!
The European Technology Platform for Nanomedicine (ETPN) and the EU-funded project ENATRANS, announce the launching of the 3rd edition of the Nanomedicine Award, which aims to promote and reward two excellent innovative nanomedicine-based solutions that could bring significant benefits to patients, answering thereby unmet medical needs. The winners in both categories will be announced and rewarded during the BIO-Europe conference in Berlin in November 2017. Apply Now!
Nanomedicine Translation around the globe - How to proper address regulatory processes for nanomedicines in different countries
6th Round of applications to the NanomedTAB is open
The Nanomedicine Translation Advisory Board (nanomedTAB) offers since 2015 a free-of-charge mentoring program to assess, advise and accelerate promising nanomedicine projects to the market, based on a team of top skills industry experts with diverse and complementary experience. The objective? Help all projects and teams to get to clinical and commercial application faster and more reliably.
Find Nanomedicine related videos on ENATRANS YouTube Channel
ENATRANS compiles videos, animated movies and recordings of inspiring talks in its YouTube Channel with a particular focus on Nanomedicine Translation.
Open call for innovative projects in personalised healthcare
The EU-funded INNOLABS project will select more than 100 innovative project ideas to accelerate and further support both financially and with services. Final submission deadline: 30 September 2017.
Disruptive Med Talk at BIO-Europe 2017 Nov 07, 2017 from 01:30 PM to 02:30 PM
Join us to discover the Disruptive event in Berlin at Bio-Europe 2017!
PR Disruptive Med Talk at BIO-Europe 2017
NEW “DISRUPTIVE MED TALKS” AT BIO-EUROPE 2017
Nanomedicine Award 2017 - Recipients
Nanomedicine Award 2017 - Recipients
The European Technology Platform on Nanomedicine (ETPN) and ENATRANS announced the 2 recipients of the Nanomedicine Award 2017
NanomedicineAward2017Winners.jpg
EURONANOMED CALL 2018 OPEN
Submit your pre-proposals for European Innovative Research & Technological Development Projects in Nanomedicine till January 16th, 2018 (17:00, CET)!
ENATRANS Webinar - The regulation Ecosystem for Nanomedicine - on 1st December, 10:00 AM CEST
ENATRANS organises this webinar to inform about the regulation Ecosystem for Nanomedicine and give pratical advice about what is required and who can help at the different steps of the Nanomedicine regulation process.

Events

12th Annual Event of the ETP Nanomedicine from Oct 17, 2017 09:00 PM to Oct 19, 2017 05:00 PM Malaga (Spain),
The 2017 edition of the ETPN General Assembly and Annual Event will take place from 17th to 19th October in Malaga (Spain)
Meet the TAB Experts - 6th TAB-in sessions in Malaga in October Jul 17, 2017 01:45 PM
Innovative nanomedicine projects selected for the TAB will be invited to attend the next TAB-in sessions to be held on October 19th, 2017 in Malaga (Spain), in the framework of the 12th ETP Nanomedicine Annual Event.
BIO-Europe 2017 from Nov 06, 2017 09:00 AM to Nov 08, 2017 06:00 PM Berlin (Germany),
A "must-attend" event and Europe's largest life science partnering conference. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
Nanomedicine Award 2017 Ceremony Nov 07, 2017 from 01:00 PM to 01:30 PM Berlin (Germany),
The Award ceremony will take place during BIO-Europe 2017 in Berlin (Germany), on 7 November 2017 at 13:00 in Room M4, level 3.
Controversies in Precision Medicine from Nov 13, 2017 12:00 AM to Nov 15, 2017 12:00 AM Berlin (Germany),
The Summit, under the leadership of Professor Dan Peer , Director of Tel Aviv University Cancer Biology Research Center, will explore the provocative scientific debates on Precision Medicine and facilitate discussions on future ways to increase the productivity of biopharmaceutical and clinical innovation.
NanoBio&Med2017 from Nov 22, 2017 12:00 AM to Nov 24, 2017 12:00 AM Barcelona (spain),
The NanoBio&Med2017 is going to present the most recent international developments in the field of Nanobiotechnology and Nanomedicine and will provide a platform for multidisciplinary communication, new cooperations and projects to participants from both science and industry.
MicroNanoConference - MNC 2017 from Dec 12, 2017 12:00 AM to Dec 13, 2017 12:00 AM Amsterdam (The Netherlands),
The international MicroNanoConference has a solid track record in bringing together the elements of the value chain. The active involvement of industry, science and user community of microsystems and nanotechnology is the hallmark of this conference.
Nano World Cancer Day 2018 Feb 02, 2018 12:00 AM Simultaneously in several European countries,
Save the date!
RegMed Forum 2017 - Advanced Disease Models Jul 20, 2017 04:40 PM
In regenerative medicine, the efficient development of new therapy options, such as cell therapies, requires suitable in-vitro disease model systems beyond the current standard. Innovative 3D cell culture approaches, 3D bioprinting and organ-on-a-chip model systems have all seen tremendous progress over the last decade. Now, even multi-organ-on-a-chip models are within reach. All these systems are reproducing in-vivo conditions of human health and disease in unprecedented ways.
Past events
Archive of past events
11th CLINAM Conference on Clinical Nanomedicine, Targeted Delivery and Precision Medicine from Sep 02, 2018 12:00 AM to Sep 05, 2018 12:00 AM Basel, Switzerland,
Save the Date!
ETPN2018 from May 28, 2018 12:00 AM to May 30, 2018 12:00 AM Berlin (Germany),
SAVE THE DATE! 2018 Edition of the General Assembly & Annual event of the ETP Nanomedicine
MedXperience - International Health Tech Summit from Mar 15, 2018 12:00 AM to Mar 16, 2018 12:00 AM Paris,
International event organised around the 4 strategic fields: diagnosis, imaging, advanced therapies and ehealth. 1 500 attendees from industrial groups, start-ups, innovative companies, healthcare professionals, universities, public organisations (research centers), institutions, investors are expected.
ENATRANS Webinar - The regulation Ecosystem for Nanomedicine Dec 01, 2017 10:00 AM online,
The translation of any new medical invention into a final product is a highly regulated and complex process. To bring a new medical product or device on the market it has to go through a long and complex process involving many authorities at regional, national and international level. To successfully manage this process it is mandatory to study and understand the different parts of the process in detail. The webinar gives an overview of the broader nanomedicine ecosystem and issues to be aware of such as regulation, pricing and reimbursement systems by providing all data about these steps in place in Europe, at the EU, and Member States level. The provided information, links and downloads will serve as a guide about what is required in which order and who can help at the different steps of the process.
Save the Date! ENATRANS Webinar - The Nanomedicine Translation HUB Dec 08, 2017 from 10:00 AM to 11:00 AM online,

Contact & Imprint

Contact & Imprint

Coordinator Contact:

Website hosted by:

VDI/VDE Innovation + Technik GmbH
Steinplatz 1
10623 Berlin
Germany

Responsible for the content of the ENATRANS Site:

Nicolas Gouze
VDI/VDE Innovation + Technik GmbH
Steinplatz 1
10623 Berlin
Germany

http://www.vdivde-it.de

Exclusion of liability

The contents of this website were compiled with due care; the data contained therein are correct, complete and up-to-date to the best of our knowledge. However, any liability or guaranty concerning the topicality, correctness or completeness of the information and data made available shall be excluded.

VDI/VDE-IT may change this website wholly or partly and/or stop operating it at its discretion any time without prior notice and is not obliged to update it.

The content of the website is copyrighted. Information or data may only be copied with VDI/VDE-IT’s prior consent. This applies in particular to the use of texts, parts of texts or pictorial material, with the exemption of material expressly offered in the “press” chapter for further dissemination.

Hyperlinks to the websites of third parties shall not be considered as agreement by VDI/VDI-IT with their contents. The availability and the contents of the linked pages are exclusively the responsibility of their providers.

If any contents of web pages should infringe applicable rules and regulations, we ask you to advise us immediately. We will then remove the corresponding page or the corresponding content as soon as possible.

Any legal claims or processes arising in connection with this website or its use shall be construed in accordance with the laws of the Federal Republic of Germany.

Downloads

2015_Delivering Nanomedicines to patients - a practical guide - Mike Eaton - ELSEVIER.pdf
ENATRANS Compedium for successful translation - testing, regulation and reimbursement.pdf
This compendium gives a broad overview of this regulatory ecosystem and issues to be aware of on the way from research proof of concept to the patient. It can be used as kind of a guidance listing the requirements and processes for the three main areas: preclinical and clinical regulations plus reimbursement.